Table 2. Clinical characteristics of study participants.
| Variables | Total population |
|---|---|
| Age (Years)a | 48(32–64) |
| Gender, n (%) | |
| Male | 55 (43%) |
| Female | 72 (57%) |
| Education (Years of study)a | 6 (4–10) |
| Smoking status, (former vs. never) n (%) | 36 (28%) |
| Pack-years of smokinga | 1.5 (0.3–5) |
| Comorbidity n (%) | 54 (43%) |
| New case n (%) | 108 (85%) |
| Time of the disease (days)a* n = 77 | 90 (60–180) (4–720) |
| Time elapsed between the end of treatment and inclusion in the study (months) | |
| 0 months n (%) | 14 (11%) |
| 1–12 months n (%) | 51 (40%) |
| 13–24 months n (%) | 52 (41%) |
| 27–252 months n (%) | 10 (8%) |
| MRC Dyspnea Scale n (%) | |
| MRC 0 | 54 (42%) |
| MRC 1 | 49(39%) |
| MRC 2 | 18 (14%) |
| MRC 3 | 5(4%) |
| MRC 4 | 1 (1%) |
| Score of radiographic abnormalitiesb | 6.6(4.14) |
a Median [interquartile range (IQR)], b Mean [Standard deviation (SD)] of four measurements
*
Defined as the time elapsed between the onset of the symptoms and diagnosis of tuberculosis.